Combined tumor necrosis factor-α (-308 G/A) and tumor necrosis factor-β (+ 252 A/G) nucleotide polymorphisms and chronicity in Egyptian children with immune thrombocytopenia

Int J Hematol. 2023 Jun;117(6):856-862. doi: 10.1007/s12185-023-03551-9. Epub 2023 Feb 18.

Abstract

Background: Primary immune thrombocytopenia (ITP) is a common autoimmune disorder. Secretion of TNF-α, TNF-β and IFN-γ plays a major role in the pathogenesis of ITP.

Objective: This cross-sectional study aimed to detect TNF-α (-308 G/A) and TNF-β (+ 252 A/G) gene polymorphism in a cohort of Egyptian children with chronic ITP (cITP) to clarify their possible association with progression to chronic disease.

Methods: The study included 80 Egyptian cITP patients and 100 unrelated age- and sex-matched controls. Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Results: Patients with TNF-α homozygous (A/A) genotype had significantly higher mean age, longer disease duration and lower platelet counts (p values 0.005, 0.024 and 0.008, respectively). TNF-α wild (G/G) genotype was significantly more frequent among responders (p = 0.049). Complete response was more frequent among wild (A/A) TNF-β genotype patients (p = 0.011), and platelet count was significantly lower among homozygous (G/G) genotype (p = 0.018) patients. Combined polymorphisms were strongly associated with susceptibility to chronic ITP.

Conclusion: Homozygosity in either gene might contribute to a worse course of disease, increased severity and poor response to therapy. Patients expressing combined polymorphisms are more prone to progression to chronic disease, severe thrombocytopenia and longer disease duration.

Keywords: Chronic ITP; Cytokines; Egyptian; Genotyping; Polymorphisms; Restriction fragment length polymorphism; TNF-α; TNF-β.

MeSH terms

  • Case-Control Studies
  • Child
  • Cross-Sectional Studies
  • Egypt
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Lymphotoxin-alpha* / genetics
  • Polymorphism, Single Nucleotide
  • Purpura, Thrombocytopenic, Idiopathic* / genetics
  • Tumor Necrosis Factor-alpha* / genetics

Substances

  • Lymphotoxin-alpha
  • Tumor Necrosis Factor-alpha
  • TNF protein, human
  • LTA protein, human